The Chemours Company
CC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,526 | $4,697 | $4,757 | $5,536 |
| - Cash | $713 | $1,203 | $1,102 | $1,451 |
| + Debt | $4,355 | $4,299 | $3,813 | $3,928 |
| Enterprise Value | $6,168 | $7,793 | $7,468 | $8,013 |
| Revenue | $5,782 | $6,078 | $6,831 | $6,345 |
| % Growth | -4.9% | -11% | 7.7% | – |
| Gross Profit | $1,151 | $1,306 | $1,616 | $1,381 |
| % Margin | 19.9% | 21.5% | 23.7% | 21.8% |
| EBITDA | $692 | $197 | $1,195 | $1,178 |
| % Margin | 12% | 3.2% | 17.5% | 18.6% |
| Net Income | $86 | -$238 | $578 | $608 |
| % Margin | 1.5% | -3.9% | 8.5% | 9.6% |
| EPS Diluted | 0.57 | -1.6 | 3.65 | 3.6 |
| % Growth | 135.6% | -143.8% | 1.4% | – |
| Operating Cash Flow | -$633 | $556 | $755 | $814 |
| Capital Expenditures | -$360 | -$370 | -$307 | -$277 |
| Free Cash Flow | -$993 | $186 | $448 | $537 |